Asahi Songwon Colors Limited secured near-unanimous shareholder approval for the appointment of Mr. Arjun Gokul Jaykrishna as Chief Executive Officer and Executive Director during its Extra Ordinary General Meeting (EGM) on August 25, 2026.

The company disclosed the final voting results on August 26, 2026, confirming that both special resolutions on the agenda were passed with overwhelming support from promoters and public shareholders.

Voting Outcome

The EGM, conducted via video conferencing and other audio-visual means, saw a total of 7,967,104 votes polled out of 11,787,262 shares held as on the record date of August 18, 2026. This represents a participation rate of 67.59%.

Resolution 1: CEO Appointment

The special resolution to appoint Mr. Arjun Gokul Jaykrishna (DIN: 08548676) as CEO and Executive Director was approved with 99.9994% of votes in favour.

Resolution 2: Loan and Guarantee Approval

The second special resolution, seeking approval for loans, guarantees, or security under Section 185 of the Companies Act, 2013, also passed with 99.9988% support.

Meeting Details

The meeting commenced at 11:30 am with a quorum present. Mrs. Paru M. Jaykrishna, Chairperson and Managing Director, delivered the opening address. Mr. Arjun G. Jaykrishna responded to shareholder queries during the session.

S. Sharda & Associates, represented by CA Naveen Kumar Mandovara (FCA 117422), served as the scrutinizer for the e-voting process. The scrutinizer’s report confirmed that all votes were cast via remote e-voting between August 22 and August 24, 2026, with no invalid votes recorded for either resolution.

The promoter group, holding 7,906,960 shares, voted in full favour of both resolutions. Among public non-institutional shareholders, who held 3,823,593 shares, only 21,999 votes were polled, reflecting lower retail participation compared to institutional and promoter blocs.

Asahi Songwon Colors reported a sharp acceleration in profitability for Q1FY27, with consolidated net profit attributable to owners surging 631% year-on-year to ₹192.32 crore (₹1,923.20 lakhs) compared to ₹31.63 crore (₹316.31 lakhs) in Q1FY26. The strong performance was underpinned by a 26% rise in consolidated revenue from operations to ₹188.91 crore (₹18,890.51 lakhs) from ₹149.88 crore (₹14,987.78 lakhs) in the prior year period, reflecting robust demand across its core chemical segments and improved cost management.

The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, at a meeting held on July 29, 2026. The statutory auditors, Talati & Talati LLP, issued an unqualified limited review report on the financial statements in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the Board appointed Mr. Sanjay Srivastava as an Additional Director (Non-Executive Independent Director) effective July 29, 2026, for a term of five years, subject to shareholder approval.

Segment Performance Drives Margin Expansion

The company’s dual-segment strategy yielded significant operational leverage. The Pigments segment, the primary revenue contributor, generated ₹155.16 crore (₹15,515.96 lakhs) in revenue, up from ₹124.50 crore (₹12,450.22 lakhs) YoY, while reporting a segment result of ₹230.82 crore (₹2,308.22 lakhs), a substantial increase from ₹78.08 crore (₹780.83 lakhs) in Q1FY26.

Simultaneously, the Life Science Chemicals (API) segment demonstrated a turnaround in profitability. API revenue rose to ₹34.54 crore (₹3,454.00 lakhs) from ₹26.83 crore (₹2,683.41 lakhs). More critically, the segment swung to a profit of ₹48.52 crore (₹485.21 lakhs) from a loss of ₹4.42 crore (₹-44.19 lakhs) in the corresponding quarter last year, highlighting improved cost management and pricing power in the active pharmaceutical ingredients space.

Financial Highlights and Standalone Results

On a standalone basis, Asahi Songwon Colors reported a net profit of ₹169.34 crore (₹1,693.36 lakhs), up from ₹55.34 crore (₹553.39 lakhs) in Q1FY26. Standalone revenue from operations grew 28% to ₹135.93 crore (₹13,592.84 lakhs) from ₹106.13 crore (₹10,613.27 lakhs). Earnings per share (basic) stood at ₹14.37 for the standalone entity and ₹16.32 on a consolidated basis, compared to ₹4.69 and ₹2.68 respectively in the previous year.

Total comprehensive income for the group reached ₹200.34 crore (₹2,003.35 lakhs), driven by positive other comprehensive income items including revaluation gains and foreign exchange adjustments. The company maintained a stable equity base with paid-up capital of ₹117.87 crore (₹1,178.73 lakhs).

What the Numbers Show

The most significant development in Q1FY27 is the structural improvement in the API segment’s contribution to overall profitability. In Q1FY26, the API segment’s loss eroded the gains from the Pigments business; in Q1FY27, both segments contributed positively to the bottom line. This shift indicates that the company has successfully navigated earlier cost pressures or inventory challenges in its life sciences vertical. Furthermore, the expansion in consolidated profit before tax to ₹253.51 crore (₹2,535.05 lakhs) from ₹42.27 crore (₹422.71 lakhs) underscores enhanced operating efficiency, as total expenses grew at a slower pace than revenue, resulting in improved gross margins across both business units.